SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-015864
Filing Date
2021-08-05
Accepted
2021-08-05 16:16:24
Documents
16
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20210805.htm   iXBRL 8-K 33606
2 EX-99.1 exhibit991_8521pressrelease.htm EX-99.1 19602
6 GRAPHIC image1a.jpg GRAPHIC 175200
7 GRAPHIC imagea.jpg GRAPHIC 291750
8 GRAPHIC logoa.jpg GRAPHIC 9327
  Complete submission text file 0001628280-21-015864.txt   850361

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20210805.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20210805_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20210805_pre.xml EX-101.PRE 12644
9 EXTRACTED XBRL INSTANCE DOCUMENT advm-20210805_htm.xml XML 10511
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 211148402
SIC: 2836 Biological Products, (No Diagnostic Substances)